Next, we test whether NPs-mediated PFKP silencing can inhibit lung cancer growth in vivo. The knockdown efficiency of NPs-encapsulated siPFKP on PFKP was assessed in vitro, as illustrated in Fig. 4F. This evidence concerns the gene PFKP and lung carcinoma.